very low density lipoprotein receptor
Last updated 2 Mar 2026
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The VLDLR gene provides instructions for making a protein called a very low-density lipoprotein (VLDL) receptor. This protein is active in many different organs and tissues, but it appears to play a particularly important role in the developing brain.
Video picks for GenesVideo library
Normal function
The VLDLR gene provides instructions for making a protein called a very low-density lipoprotein (VLDL) receptor. This protein is active in many different organs and tissues, but it appears to play a particularly important role in the developing brain.
The VLDL receptor works together with a protein called reelin. Reelin fits into the VLDL receptor like a key in a lock, which triggers a series of chemical reactions within the cell. This series of reactions is known as a signaling pathway. During early brain development, the reelin signaling pathway helps guide immature nerve cells (neuroblasts) to their appropriate locations.
Conditions referring to this gene or chromosome
Other names
CARMQ1
CHRMQ1
VLDLRCH
Patient picks for Genes

Heart health and blood vessels
Can you lower cholesterol through diet alone?
By now, the health risks of high cholesterol are well documented. But do you need to change every aspect of your lifestyle to protect yourself against heart disease and stroke or can diet alone tame your cholesterol levels?
by Milly Evans

Treatment and medication
Statins and other lipid-lowering medicines
Statins work by blocking the action of a certain chemical (enzyme) which is needed to make cholesterol, and by removing some forms of cholesterol from the blood.
by Dr Rachel Hudson, MRCGP

Heart health and blood vessels
DASH diet - healthy eating that helps lower blood pressure
The DASH diet is a heart-healthy diet that lowers blood pressure and cholesterol. Far from being specialist, this eating plan can benefit many people - whether you're looking to improve poor heart health, manage a related condition, or protect yourself against future health problems.
by Lynn Stephen

Heart health and blood vessels
7 seasonal habits to help lower your cholesterol
Feeling the need to cosy up and slow down as the colder months kick in? You’re not alone - it’s rooted in proven biological and neurological changes rather than laziness. But while enjoying a slower pace can be enjoyable, some of the habits that come with it might be quietly raising your cholesterol.
by Claire Kenny

Diet and nutrition
Can red yeast rice lower your cholesterol?
Red yeast rice extract has been used for centuries in traditional Chinese medicine. With a list of wellness perks attached to its name, it's recently gained popularity as a dietary supplement. But what are the health advantages of red yeast rice, and are there any side effects?
by Victoria Raw

Women's health
Ferritin face - signs of low iron, or viral skin trend?
There’s a new viral wellness term in town called ‘ferritin face’. It’s being used to describe the apparent link between low iron stores and symptoms such as dark circles under your eyes, dull, tired-looking skin, cracked lips, and hair loss. But what exactly is ferritin, and can low levels really affect your facial appearance? We spoke to consultant gynaecologist, Dr Lamia Zafrani, and consultant dermatologist, Dr Sidra Khan, to demystify what ferritin is, how it affects our bodies, and why women are more vulnerable to lower levels.
by Hannah Boynton-Forshaw
Related patient information and medicines

Patient information leaflet
Familial hypercholesterolaemia
Familial hypercholesterolaemia is inherited high cholesterol. ...ne (apolipoprotein B): a fault with this gene means LDL cholesterol can’t bind well to LDL receptors so that blood levels of LDLDr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Patient information leaflet
High cholesterol
Cholesterol is a fat chemical (lipid) that is made in the cells in your body. Cholesterol is carried in the... When low-density lipoproteins (LDL cholesterol) carry cholesterol this is referred to as 'bad' cholesterol. Higher levels of LDL cholesterol in your blood cause an increased risk of lipoprotein disorders and cardiovascular disease (heart.

Patient information leaflet
Statins and other lipid-lowering medicines
However, national guidelines recommend that people who have not been diagnosed with cardiovascular disease, but would benefit from taking a statin to... This is a 'high-intensity' statin - the aim of giving high-intensity statins is to reduce your low-density lipoprotein (LDL) cholesterol (sometimes called the 'bad cholesterol') by at least 40%..

Patient information leaflet
IgA nephropathy
IgA nephropathy is a condition in which a protein causes damage to the kidneys. The protein is called immunoglobulin A or IgA. Nephropathy means an illness that damages the kidney. The main job of the kidneys is to clear waste materials from the body and maintain a normal balance of fluids and chemicals in the body. The kidneys also have other.

Patient information leaflet
X-ray test
X-ray tests show bones and certain other tissues. What are X-rays. X-rays are a type of high-energy radiation. An X-ray machine can produce short bursts of X-rays. The rays pass easily through fluids and soft tissues of the body. However, dense tissue such as bone will block some of the X-rays. (Density means how much of something there is in a.

Patient information leaflet
Can I take Atorvastatin and Losartan together?
There is no significant interaction between atorvastatin and losartan. These two medicines are very commonly prescribed together to manage high blood pressure and high cholesterol. You can take atorvastatin Atorvastatin tablets and losartan Losartan - an angiotensin receptor blocker together as they do not interact with each other. Atorvastatin.
Further reading and references
- very low density lipoprotein receptor; MedlinePlus, National Library of Medicine.
- Boycott KM, Bonnemann C, Herz J, Neuert S, Beaulieu C, Scott JN, Venkatasubramanian A, Parboosingh JS. Mutations in VLDLR as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome). J Child Neurol. 2009 Oct;24(10):1310-5. doi: 10.1177/0883073809332696. Epub 2009 Mar 30.
- Boycott KM, Flavelle S, Bureau A, Glass HC, Fujiwara TM, Wirrell E, Davey K, Chudley AE, Scott JN, McLeod DR, Parboosingh JS. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am J Hum Genet. 2005 Sep;77(3):477-83. doi: 10.1086/444400. Epub 2005 Jul 22.
- Boycott KM, MacDonald SK, Parboosingh JS. VLDLR Cerebellar Hypoplasia. 2008 Aug 26 [updated 2020 Feb 27]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1874/
- Micalizzi A, Moroni I, Ginevrino M, Biagini T, Mazza T, Romani M, Valente EM. Very mild features of dysequilibrium syndrome associated with a novel VLDLR missense mutation. Neurogenetics. 2016 Jul;17(3):191-5. doi: 10.1007/s10048-016-0488-y. Epub 2016 Jun 2.
- Moheb LA, Tzschach A, Garshasbi M, Kahrizi K, Darvish H, Heshmati Y, Kordi A, Najmabadi H, Ropers HH, Kuss AW. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome. Eur J Hum Genet. 2008 Feb;16(2):270-3. doi: 10.1038/sj.ejhg.5201967. Epub 2007 Nov 28.
- Newman JM, Vogel H. Neuropathological findings of very low-density lipoprotein receptor-related cerebellar hypoplasia in a full-term fetus. J Neuropathol Exp Neurol. 2025 Dec 1;84(12):1135-1142. doi: 10.1093/jnen/nlaf110.
- Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200.
- Tissir F, Goffinet AM. Reelin and brain development. Nat Rev Neurosci. 2003 Jun;4(6):496-505. doi: 10.1038/nrn1113. No abstract available.
- Turkmen S, Hoffmann K, Demirhan O, Aruoba D, Humphrey N, Mundlos S. Cerebellar hypoplasia, with quadrupedal locomotion, caused by mutations in the very low-density lipoprotein receptor gene. Eur J Hum Genet. 2008 Sep;16(9):1070-4. doi: 10.1038/ejhg.2008.73. Epub 2008 Mar 26.
- Wali GM, Wali G. Broadening the Clinical Spectrum of Very Low Density Lipoprotein Receptor Associated Dysequilibrium Syndrome. Mov Disord Clin Pract. 2021 Apr 3;8(4):619-623. doi: 10.1002/mdc3.13184. eCollection 2021 May. No abstract available.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

